Head and Neck Cancer Cells Exhibit an Adaptive Response to the AKT-inhibitor Perifosine Characterized by Increased Glucose Metabolism and Altered Signaling Through the AKT Pathway
Keyword(s):
Keyword(s):
2019 ◽
Vol 60
(3)
◽
pp. 289-297
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 135
(2)
◽
pp. 190
◽